MATWIN Acceleration programme



Service ID:

Service description

The START six-month (or GROW three-month) acceleration programme targeting all EIC beneficiaries aims to boost innovation transfer potential of research advances with applications in oncology. The service launches an annual call and provides access to expertise, coaching/mentoring, networking and partnership opportunities. 

Main activities of the programme: 

  • Preselection pitch: Oral pitch of 8-10 minutes followed by a discussion of 10 minutes with the preselection jury (Biotechs, academic and investors representatives). Written report from the jury experts summarizing the project’s strengths and weaknesses. For the GROW program, candidates are selected directly from the MATWIN Board (MIB) to join the program at the second coaching session (see below). 
  • Personalised coaching/mentoring: Preselected EIC beneficiaries benefit from coaching sessions to optimise the project structuration, its industrial orientation and 1h mentoring session with one MIB member to prepare for the MIB interview. 
  • MIB interview: a 20-minute presentation of the EIC beneficiaries’ project followed by a 20-minute. question period with the MIB. Written recommendations and individual feedback issued after the meeting providing guidelines for a successful development plan and arguments for early-stage investment decision-making. Project leaders gain experience with their project presentation and might initiate collaborations with some MIB members.

Selected EIC beneficiaries for MIB interview will be offered a free access pass to the MEET2WIN Partnering Convention (Service ID: EP40S3). 

This service will provide EIC beneficiaries with the following outcomes: 

a) improvement of value proposition and development plan, b) validation of product market positioning, c) increased knowledge for market entry strategy, d) showcase opportunities to ease access to strategic partners and investors.

Technology Readiness Level
TRL 1 – Basic principles observed
TRL 2 – Technology concept formulated
TRL 3 – Experimental proof of concept
TRL 4 – Technology validated in lab
TRL 5 – Technology validated in relevant environment
TRL 6 – Technology demonstrated in relevant environment
TRL 7 – System prototype demonstration in operational environment
TRL 8 – System complete and qualified
TRL 9 – Actual system proven in operational environment
Disclaimer related to service

The programme will admit any EIC beneficiary entities working on oncology innovation whose project is selected by the MIB, with a maximum of 3 representatives per entities. There is a Programme Budget per EIC Beneficiary supported by MATWIN that will need to be reimbursed in case of success post Programme. For more information, see the MATWIN Charter on:

Financial requirements

€1000 VAT excl. if selected by the preselection jury. Success fees will apply in case of positive results (e.g., partnership agreement signature, fundraising).